TABLE 3 from A Randomized Phase III Study of Arfolitixorin versus Leucovorin with 5-Fluorouracil, Oxaliplatin, and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer: The AGENT Trial
收藏NIAID Data Ecosystem2026-05-01 收录
数据链接：
官方服务：
资源简介：
AEs with frequency ≥10% in either trial arm (safety population)
创建时间：
2024-01-04
